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ABSTRACT 
 
Background: The processes underlying persistence and remission of attention-deficit/hyperactivity 
disorder (ADHD) are poorly understood. We aimed to examine whether cognitive and 
neurophysiological impairments on a performance monitoring task distinguish between ADHD 
persisters and remitters.  
Methods: On average six years after initial assessment, 110 adolescents and young adults with 
childhood ADHD (87 persisters, 23 remitters) and 169 age-matched controls were compared on 
cognitive-performance measures and event-related potentials (ERPs) of conflict monitoring (N2) and 
error processing (ERN, Pe) from an arrow flanker task with low- and high-conflict conditions. ADHD 
outcome was examined with parent-reported symptoms and functional impairment measures using 
a categorical (DSM-IV) and a dimensional approach.  
Results: ADHD persisters were impaired compared to controls on all cognitive-performance and ERP 
measures (all p<0.05). ADHD remitters differed from persisters, and were indistinguishable from 
controls, on the number of congruent (low-conflict) errors, reaction time variability (RTV), ERN and 
Pe (all p≤0.05). Remitters did not differ significantly from the other groups on incongruent (high-
conflict) errors, mean reaction time and N2. In dimensional analyses on all participants with 
childhood ADHD, ADHD symptoms and functional impairment at follow up were significantly 
correlated with congruent errors, RTV and Pe (r=0.19-0.23, p≤0.05).  
Conclusions: Cognitive and neurophysiological measures of attention-vigilance and error detection 
distinguished ADHD remitters from persisters. These results extend our previous findings with other 
tasks (Cheung et al. 2015), and indicate that such measures are markers of remission and candidates 
for the development of non-pharmacological interventions. 
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INTRODUCTION 
 
The identification of cognitive and neural processes underlying the trajectories of persistence and 
recovery from childhood-onset disorders during the transition to adulthood has the potential to 
prevent negative long-term outcomes (1, 2). Attention-deficit/hyperactivity disorder (ADHD) is a 
neurodevelopmental disorder affecting 5-6% of children and adolescents worldwide (3, 4). ADHD 
often persists into adulthood, where the prevalence rate is around 2-3% (5), with severe impact on 
many aspects of individuals’ lives (6, 7). Although in a proportion of cases ADHD symptoms reduce to 
subclinical levels from childhood to adulthood (8), little is known about the compensatory processes 
and enduring deficits of ADHD. 
 
It has been proposed that the cognitive processes associated with persistence of ADHD across 
development may be separate from those linked to the remission of the disorder (9). However, 
empirical data to date are inconsistent with regard to the exact pattern of cognitive impairments 
that distinguish ADHD remitters from persisters. While some studies comparing ADHD remitters and 
persisters have linked remission to better executive function performance (1, 10), other studies have 
found no differences between ADHD remitters and persisters in adolescence and adulthood on 
measures of executive functions (11-15). 
 
The assessment of neurocognitive processes using cognitive and brain activity data may allow a 
deeper understanding of the developmental trajectories of ADHD. Our recent investigation of 
adolescents and young adults with childhood ADHD assessed on a range of cognitive, event-related 
potential (ERP) and electroencephalography (EEG) measures found that ADHD remitters differed 
from persisters, but not from controls, on preparation-vigilance measures (RTV, omission errors, ERP 
activity of response preparation, and delta and theta activity) and actigraph data on movement. 
Executive-function processes of inhibition and working memory (commission errors, digit span 
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backwards and ERP activity of inhibitory control), instead, were not sensitive to ADHD 
persistence/remission, as ADHD remitters showed an intermediate pattern between persisters and 
controls, without significant differences from either group (14). Further combined investigations of 
cognitive and neurophysiological data may aid our understanding of the mechanisms underlying 
ADHD remission and persistence. 
 
Neurocognitive impairments in ADHD include deficits in performance monitoring, an essential 
cognitive ability in goal-directed behavior to monitor ongoing performance and adjust response 
selection (16-18). The investigation of performance-monitoring impairments with ERP parameters, 
including the N2 and the error-related negativity (ERN or Ne) and positivity (Pe), in individuals with 
ADHD may provide new information to elucidate the neurocognitive pathways of remission. The N2 
is a fronto-central stimulus-locked negative deflection mostly observed 200-400 ms after the 
presentation of stimuli inducing high conflict (such as incongruent stimuli) and when a correct 
response is made (17, 19). This ERP reflects a conflict-monitoring process, as it results from the 
conflict arising from two competing responses and evaluation of the correct response (19). When a 
participant makes an error, the ERN, a fronto-central response-locked negative deflection at around 
0-150 ms is observed, followed by the Pe, a centro-parietal positive enhancement at around 200-400 
ms after response (20-22). The ERN is thought to reflect unconscious activity of a generic response-
monitoring system immediately after a mistake is made, while the Pe is thought to represent 
conscious error processing to adjust response strategy (23).  
 
In ADHD, N2 attenuation in the flanker task has been reported in children and adults with ADHD (24-
26), although two smaller studies failed to replicate this finding (27, 28). With regard to ERN and Pe 
attenuation in ADHD, a recent meta-analysis found an overall ERN attenuation in performance 
monitoring tasks (29). Pe attenuations in ADHD samples were significant in Go/NoGo tasks, but not 
flanker tasks. Yet, data on these ERPs in individuals with ADHD are overall limited, and study samples 
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have remained small. Furthermore, studies have not, to date, investigated the association between 
neurophysiological performance monitoring and ADHD persistence and remission. One recent study 
showed that ERN and Pe deficits may be improved with motivational incentives or methylphenidate 
medication in ADHD groups (30), suggesting malleability of the error-processing impairments in 
ADHD.  
 
In the present study, we aimed to extend our recent findings (14) by investigating cognitive and 
neurophysiological impairments from a performance monitoring task in adolescents and young 
adults with persistent and remitted ADHD. We examined ADHD outcome with parent-reported 
symptoms and functional impairment measures using both a categorical (DSM-IV) and a dimensional 
approach. Based on our previous results and evidence of potentially malleable neurophysiological 
error processing, we predicted that cognitive measures underlying non-executive processes and 
ERPs of error processing (ERN/Pe) would distinguish between ADHD persisters and remitters, and 
represent markers of remission. We further predicted that cognitive indices of executive control 
would not vary with persistence or remission of ADHD. No formal predictions were made for ERP 
measures of conflict monitoring (N2), owing to absence of any evidence suggesting a possible 
association with remission or persistence of ADHD. 
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METHODS AND MATERIALS 
 
Sample  
 
The sample consists of 279 participants, who were followed up on average 5.8 years (SD=1.1) after 
initial assessments: 110 had a diagnosis of DSM-IV combined-type ADHD in childhood (10 sibling 
pairs and 90 singletons) and 169 were control participants (76 sibling pairs and 17 singletons) (14, 
31). Participants with ADHD were initially recruited from specialized ADHD clinics (32), and control 
participants from schools in the UK. Information on any diagnosed neurodevelopmental and 
psychiatric conditions and medication use were collected through neuropsychiatric screening. 
Exclusion criteria at both assessments included: IQ < 70, autism, epilepsy, brain disorders and any 
genetic or medical disorder associated with externalizing behaviors that might mimic ADHD. Other 
comorbidities were not excluded in order to have an ADHD sample that is representative of the 
clinical population. At follow up, we excluded six control participants who met DSM-IV ADHD criteria 
based on the parent-reported Barkley Informant Rating Scale (33) and six participants with ADHD 
who had missing parent ratings of clinical impairments. Two participants with childhood ADHD, who 
did not meet ADHD symptom criteria but met clinical levels of impairment at follow up, were also 
excluded to minimise heterogeneity in the sample. 
 
Among those with childhood ADHD, 87 (79%) continued to meet clinical (DSM-IV) levels of ADHD 
symptoms and impairment (ADHD ‘persisters’), while 23 (21%) were below the clinical cut-off (ADHD 
‘remitters’) (31). Among ADHD remitters, 14 displayed ≥ 5 items on either the inattention or 
hyperactivity/impulsivity symptom domains, but did not show functional impairment. ADHD 
persisters, remitters and controls did not differ in age, but there were significantly more males in the 
remitted group than in the other two groups, with no females among ADHD remitters (Table 1). 
Participants attended a single research session for clinical, IQ and cognitive-EEG assessments. Almost 
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half (47%) of the participants with childhood ADHD were being treated with stimulant medication at 
follow up. Those who were on medication scored significantly higher on ADHD symptoms (F=11.34, 
p<.01) and functional impairment (F=5.22, p<.01) than those who were not taking medication. 
However, the proportion of participants on medication did not differ between ADHD persisters and 
remitters (χ²=1.95, p=.16). A 48-hour ADHD medication-free period was required prior to 
assessments. Three ADHD persisters (3.4%) were also on antidepressant medication, but were not 
asked to stop taking them for ethical reasons. These participants were included in all analyses as 
their exclusion did not alter the results. Parents of all participants gave informed consent following 
procedures approved by the London-Surrey Borders Research Ethics Committee (09/H0806/58). 
 
ADHD diagnosis 
 
The diagnostic interview for ADHD in adults (DIVA) (34) was conducted by trained researchers with 
parents of the ADHD probands, to assess DSM-IV-defined ADHD presence and persistence. Raw 
scores for inattention and hyperactivity/impulsivity symptoms (range 0-9 for each dimension) were 
generated for each participant. Evidence of impairment commonly associated with ADHD was 
assessed with the Barkley’s functional impairment scale (BFIS) (33) during interviews with parents. 
Each item ranges from 0 (never or rarely) to 3 (very often). Participants were classified as ‘affected’ 
at follow-up if they scored ≥ 6 in either the inattention or hyperactivity/impulsivity domains on the 
DIVA and ≥ 2 on two or more areas of impairments on the BFIS. We defined ADHD outcome using a 
categorical definition of persistence based on diagnoses, as well as a dimensional approach based on 
levels of symptoms of ADHD and impairments measured as continuous traits.  
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IQ assessment 
 
An estimate of IQ was derived with the vocabulary and block design subtests of the Wechsler 
Abbreviated Scale of Intelligence (WASI) (35). 
 
Task 
 
The task was an adaptation of the Eriksen Flanker paradigm designed to increase cognitive load as 
used in previous studies (24, 25, 36). In each trial a central black fixation mark was replaced by a 
target arrow (a black 18 mm equilateral triangle). Participants had to indicate whether this arrow 
pointed towards the left or right by pressing corresponding response buttons with their left or right 
index fingers. Two flanker arrows identical in shape and size to the target appeared 22 mm above 
and below the centre of the target arrow 100 ms prior to each target arrow. Both flankers either 
pointed in the same (congruent) or opposite (incongruent) direction to the target. As such, conflict 
monitoring is maximal during the incongruent condition. When the target appeared, both target and 
flankers remained on the screen for a further 150 ms, with a new trial being presented every 1650 
ms. Two hundred congruent and 200 incongruent trials were arranged in 10 blocks of 40 trials over 
13 minutes. For further details on the task see Supplement 1. Cognitive-performance measures of 
mean reaction time (MRT), RTV (SD of RTs) and number of errors (left-right errors occurring when 
participants chose the wrong left or right response) were calculated separately for congruent and 
incongruent conditions.  
 
Electrophysiological recording and processing  
 
The EEG was recorded from a 62 channel DC-coupled recording system (extended 10–20 montage), 
using a 500 Hz sampling-rate, impedances under 10 kΩ, and FCz as the recording reference. The 
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electro-oculograms (EOGs) were recorded from electrodes above and below the left eye and at the 
outer canthi. EEG data were analyzed using Brain Vision Analyzer 2.0 (Brain Products, Germany). 
Raw EEG recordings were down-sampled to 256 Hz, re-referenced to the average of all electrodes 
(turning FCz into an active channel), and filtered using Butterworth band-pass filters (0.1-30 Hz, 24 
dB/oct). All trials were visually inspected for electrical artifacts or obvious movement, and sections 
of data containing artifacts were removed manually. Ocular artifacts were identified using the 
infomax Independent Component Analysis algorithm (ICA) (37). Sections of data containing artifacts 
exceeding ± 100 μV or with a voltage step greater than 50 μV were automatically rejected. Baseline 
correction was applied using the -300 to -100 ms pre-target (-200 to 0 ms pre-flanker) interval. 
 
Analyses of ERPs of performance monitoring were restricted to incongruent trials, as the task used in 
this study is known to elicit strong N2, ERN and Pe components in high-conflict, but not in low-
conflict, conditions (24, 25, 36). Data were segmented based on (1) stimulus-locked incongruent 
trials where a correct response was made and (2) response-locked (error-related) incongruent trials 
where an incorrect response was made. Individual averages were created based on each condition, 
requiring ≥ 20 clean segments for each participant. After averaging, the electrodes and latency 
windows for ERP analyses were selected based on previous studies (23-25, 38), topographic maps 
and the grand averages (Figures 1-2). The N2 was measured as maximum negative peak at Fz and 
FCz between 250-450 ms after target onset. The ERN was defined with respect to the preceding 
positivity (PNe, -100-50 ms) and measured at FCz between 0-150 ms. This peak-to-peak measure has 
proven to be a robust measure of this component (20, 23, 39) and was favored over a peak-to-
baseline (maximal amplitude) measure as the former distinguished ADHD from controls in 
independent samples using this version of the Eriksen flanker task (24, 25, 40); it was therefore the 
ideal candidate in relation to ADHD remission/persistence (for further details see Supplement 1). 
The Pe was measured as maximum positive peak at CPz between 150-450 ms after an erroneous 
response on incongruent trials.  
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Statistical analyses 
 
For RTV and errors we tested overall effects of group (ADHD persisters, remitters, controls), 
condition (congruent, incongruent) and group*condition interaction using random intercept models 
in Stata (StataCorp, College Station, TX) to control for genetic relatedness of the sibling pairs in a 
repeated-measures design. A random intercept model was also run to test the effect of group, scalp 
site (Fz, FCz) and group*site interaction on the N2. ERN and Pe were analyzed with regression 
models with dummy variables to identify overall group effects, controlling for sibling relatedness 
with the ‘robust cluster’ command in Stata. Age correlated significantly with several of the cognitive-
ERP measures (Table S1, Supplement 1), and was therefore included as a covariate in group 
analyses. On measures that indicated a group effect, post-hoc regressions were performed. The 
majority of our sample consisted of males (80%), and thus primary analyses were performed on the 
whole sample without accounting for sex differences. As groups were not matched on gender (no 
female in the sample remitted from ADHD) (Table 1), analyses were re-run with the females (15 
ADHD persisters and 41 controls) removed. Cohen’s d effect sizes are presented along with means, 
SDs and test statistics for the group analyses (Table 2), where 0.20 is considered a small effect, 0.50 
a medium effect and 0.80 a large effect (41). Pearson correlations examined which measures 
correlated with DIVA ADHD symptom scores and functional impairment, in those with a childhood 
ADHD diagnosis, with age and gender included as covariates.  
 
As ADHD persisters had a lower IQ than remitters (Table 1) (14), and higher IQ in childhood was 
associated with ADHD remission at follow-up in this sample (31), all analyses were also re-run 
controlling for IQ. All cognitive-ERP measures were skewed and log-transformed to normal. Three 
participants (ADHD persisters) were excluded from the N2 analysis and 39 (13 ADHD persisters 
(15%), 3 ADHD remitters (13%), 23 controls (14%)) from the ERN/Pe analysis due to having < 20 
Michelini, Kitsune et al.   11 
 
artifact-free ERP segments, similar to previous studies using this paradigm (24, 25) and reflecting a 
similar exclusion ratio across groups.  
 
[Table 1 about here] 
 
RESULTS 
 
Group differences 
 
An overall group effect emerged on all cognitive-performance and ERP measures (Table 2, Figures 1-
2). Post-hoc analyses showed that ADHD persisters had significantly higher MRT, RTV, number of 
errors, enhanced N2 (at Fz, but with a trend for reduction at FCz, pointing to topographic 
differences, as shown in Figure S1, Supplement 1) and reduced ERN and Pe compared to controls, 
with small-to-large effect sizes. Significant differences between ADHD remitters and persisters 
emerged on congruent and incongruent RTV, congruent errors, ERN and Pe, with medium-to-large 
effect sizes. ADHD remitters did not differ from persisters on MRT in either condition, on 
incongruent errors and N2, with null-to-small effect sizes. ADHD remitters and controls significantly 
differed on incongruent RTV, with a medium effect size, and at trend-level with small effect sizes for 
incongruent errors and incongruent MRT.  
 
Controlling for IQ, group effects on MRT in both conditions and N2 at FCz were non-significant (Table 
2). Differences between remitters and persisters became non-significant in incongruent RTV, and 
trends in ERN and Pe. Remitters and controls differed at trend-level in incongruent RTV, but not in 
incongruent errors. Results for other variables remained unchanged. When repeating the analyses 
with females removed, the difference between ADHD persisters (n=63) and remitters (n=20) became 
a trend for the ERN and non-significant for the Pe. Given the small female sample sizes (n=15; of 
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which only n=11 with data on ERN and Pe) and the discrepancy in the size of male and female 
groups, sex differences were not directly tested. Yet, the effect sizes in the male-only sample (d=0.47 
for the ERN, d=0.34 for the Pe) were comparable or only slightly reduced compared to those of the 
full sample. Remitters significantly differed from controls on incongruent MRT, congruent and 
incongruent RTV, but not on incongruent errors. All other results remained unchanged. For further 
details see Supplement 1. 
 
[Table 2 about here] 
 
Associations with ADHD symptoms and impairments 
 
Among those with childhood ADHD (n=110), both ADHD symptoms and impairment at follow up 
significantly correlated with the Pe (Table 3). ADHD symptoms also significantly correlated with RTV 
in both conditions, and functional impairment with congruent errors and at trend level with 
incongruent RTV and N2 at Fz. When IQ was controlled for, the correlation of ADHD symptoms or 
impairment with RTV became non-significant, and the correlation between functional impairment 
and congruent errors became a trend (Table 3). 
  
[Table 3 about here] 
 
DISCUSSION 
 
In this first large scale investigation of cognitive and neurophysiological performance monitoring in 
adolescents and young adults with ADHD we found that ADHD remitters had enhanced cognitive 
processes of attention-vigilance (RTV and congruent errors) and neurophysiological error processing 
(ERN and Pe) compared to persisters. Attention-vigilance measures and conscious error processing 
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were also associated with the continuum of ADHD symptoms and impairment at follow up. 
Conversely, measures of executive control (incongruent errors), speed of processing (MRT) and 
neurophysiological conflict monitoring (N2) did not distinguish remitters from persisters, thus were 
not sensitive to remission or persistence of the disorder. Processes of attention-vigilance and 
neurophysiological error processing can be markers of remission from ADHD, and may be sensitive 
to the effects of training or compensatory mechanisms. 
 
RTV, measuring intra-individual variability in RT, and number of congruent errors in the low-conflict 
condition distinguished ADHD remitters from persisters, but not from controls, and were also 
correlated with continuous ratings of ADHD symptoms and impairment. Impairments in such 
measures in the congruent condition of the flanker task may result from lapses in attention, and 
index attention-vigilance processes. Neurophysiological measures of error processing (ERN and Pe), 
showed the same association with ADHD remission. Conscious error processing (Pe) also correlated 
with the continuous ADHD symptoms and functional impairments at follow up. Of note, the group 
difference observed on this peak-to-peak ERN were likely explained by the voltage change from the 
PNe to the negative ERN peak (see Supplement 1). This measure captures the response-locked 
oscillatory pattern immediately before and after an error is made, and as such may reflect early 
attentional processes linked to automatic error detection. Conversely, incongruent errors in the 
high-conflict condition, likely reflecting a failure in executive control, and MRT in left-right responses 
at every trial, likely measuring speed of processing in this task that induces high cognitive demands, 
did not distinguish ADHD remitters from persisters. Similarly, neurophysiological conflict monitoring 
(N2) did not differ between ADHD groups, potentially indicating suboptimal parallel stimulus 
processing regardless of remission/persistence (17, 42). Remitters also showed lower RTV in the 
incongruent condition than persisters, but were still impaired compared to controls. Given the 
higher levels of executive control elicited in the incongruent condition, this could result from joint 
Michelini, Kitsune et al.   14 
 
influences of both attention-vigilance and executive processes. Therefore, RTV in the incongruent 
condition may be less sensitive to remission than in the congruent condition.  
 
Primary analyses did not control for IQ, as lower-mean IQ in ADHD samples represents one of 
multiple cognitive processes underlying ADHD pathophysiology (43, 44), and the etiological 
influences shared between ADHD and IQ are largely separate from those shared with other cognitive 
impairments (45-47). Thus by removing IQ effects when investigating the relationship between 
ADHD and cognitive-ERP variables one may also control for features of ADHD related to IQ (48, 49). 
In this sample ADHD remission was associated with higher IQ measured both in childhood and at 
follow up (14, 31). As such, it may be that higher IQ represents a potential compensatory mechanism.  
To test the association between cognitive-ERP measures and remission/persistence beyond the 
influence of IQ, we also repeated the analyses covarying for IQ. When controlling for IQ, overall 
group differences for MRT were no longer significant, suggesting that group differences on this 
measure may reflect ADHD impairments related to IQ. Moreover, remitters were more similar to 
persisters in some markers of remission (RTV, ERN and Pe) when removing the IQ effects. This 
further points to an association between IQ and better cognitive-neurophysiological profiles in ADHD 
remitters.  
 
The present study extends the findings in our previous investigation that used a cued continuous 
performance test (CPT-OX), a four-choice RT task and WASI measures of IQ and digit span (14). 
Attention-vigilance and error detection showed a similar pattern to that found in our previous 
analyses for preparation-vigilance measures (RTV, omission errors, ERP activity of response 
preparation, and delta and theta activity), while executive control (measured by incongruent errors), 
speed of processing (MRT for left-right responses) and conflict monitoring (N2) did not distinguish 
remitters from persisters, similar to measures of inhibition and working memory in our previous 
investigation (14). ADHD remitters showed an intermediate pattern between persisters and controls 
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on this latter group of measures: they showed no significant differences from either group on the 
N2, but trend-level differences from controls on incongruent errors and MRT, suggesting that the 
latter two measures may potentially represent markers of enduring deficits. Our findings align with 
four recent studies reporting no differences between ADHD remitters and persisters in executive 
control (11-14), but not with two earlier studies that suggested a link from ADHD remission to better 
executive function (1, 10). More broadly, our findings are in line with evidence for a separation of 
ADHD neurocognitive impairments into bottom-up and top-down processes supported by 
genetically-sensitive studies (32, 50). Our results are also consistent with reports of ADHD-sensitive 
improvement following rewards in RTV and ERPs of error processing (30, 51, 52), suggesting that 
such processes are malleable and may improve with the additional allocation of cognitive arousal 
and motivational incentives in ADHD samples. Future studies may further characterize the 
relationship between ADHD outcome and performance/conflict monitoring processes by 
using tasks with different ratios of congruent and incongruent trials, which may produce 
stronger enhancement of conflict processes (53), potentially coupled with single-trial measures 
to examine trial-to-trial adjustments (54).  
 
A limitation of this study is that, despite the large sample size, the low ADHD remission rate at 
follow-up resulted in a relatively small group of remitters. Therefore we could not rule out the 
possibility that some non-significant differences between remitters and other groups could be due 
to low power. However, we observed medium-to-large effect sizes (d=0.44-0.75) between persisters 
and remitters in measures representing markers of remission, but small or negligible effect sizes 
(d=0.02-0.28) in measures not sensitive to ADHD outcome at follow-up, suggesting this study had 
sufficient power to detect the major correlates of remission with the current sample sizes. Secondly, 
when we repeated the analyses for males only, differences between remitters and persisters in the 
ERN and Pe were reduced. However, the small sample of females did not allow a direct examination 
of sex differences. Future studies, including a higher number of female participants, are needed to 
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further investigate these processes also in females. Finally, our sample included young adults as well 
as adolescents, who are still undergoing rapid cortical maturation. While we controlled for age in all 
analyses, future follow-up assessments with participants having reached adulthood and when more 
ADHD participants may have remitted could clarify matters further.  
 
Overall, we report that attention-vigilance and neurophysiological error processes were impaired in 
ADHD persisters but not in remitters, and may be sensitive to compensatory mechanisms in those 
who remit from the disorder. These processes may be targets for non-pharmacological interventions 
or behavioral training aimed at alleviating some of the long-term outcomes of ADHD. Conversely, 
cognitive measures of executive control, speed of processing and conflict monitoring were not 
sensitive to ADHD remission/persistence. Considering the importance of using a broad range of 
cognitive and neural measures in investigating the mechanisms underlying neurodevelopmental 
disorders (2), our cognitive and neurophysiological investigation provides an improved 
understanding of the trajectories to ADHD remission and persistence. Future studies should aim to 
investigate the neural sources and neurobiological mechanisms underlying these markers of 
remission, in order to pave the way towards the development of new interventions aimed at 
stimulating processes that are sensitive to remission to reduce severe long-term outcomes of the 
disorder.  
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FIGURES 
 
Figure 1. Grand average response-locked ERPs of the ERN at FCz electrode between 0-150 ms (A) 
and the Pe at CPz electrode between 150-450 ms (B) after an erroneous response on the 
incongruent trials for ADHD persisters (ADHD-P, in red), ADHD remitters (ADHD-R, in green) and 
control participants (Controls, in black), with topographic maps. 
 
Figure 2. Grand average stimulus-locked ERPs of the N2 at Fz and FCz electrodes between 250-450 
ms after incongruent stimuli where a correct response was made for ADHD persisters (ADHD-P, in 
red), ADHD remitters (ADHD-R, in green) and control participants (Controls, in black), with 
topographic maps. 
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Table 1. Sample demographics divided by group, with test for group differences 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: F = females, M =  males.  
Notes: Group differences on gender were tested via Chi-square test; group differences on age and IQ 
were tested with regression models. Group differences in gender, age and IQ were previously 
reported in another paper on this sample (14).  
**p<.01; *p<.05. 
 
 
 
Table 2. Descriptive statistics and group comparison on cognitive-performance and ERP measures 
  
 ADHD-
P 
ADHD-
R 
Ctrl 
 
p ADHD-
P vs 
Ctrl 
ADHD-P 
vs 
ADHD-R 
ADHD-R 
vs Ctrl 
p p p 
Gender 
(M:F) 
72:15 23:0 129:40 .02
* 
.24 .03* <.01** 
Age, 
mean 
(SD) 
18.27 
(3.03) 
18.89 
(3.06) 
18.77 
(2.19) 
.15 - - - 
IQ, 
mean 
(SD) 
96.20 
(15.33) 
104.57 
(13.63) 
109.98 
(12.42) 
<.0
1** 
<.01** .02* .10 
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ADH
D-P 
ADH
D-R 
Ctrl Group Comparison Covarying IQ 
 mea
n  
(SD) 
mea
n  
(SD) 
mea
n  
(SD) 
p ADHD-P 
vs Ctrl 
ADHD-P 
vs 
ADHD-R 
ADHD-R 
vs Ctrl 
p ADHD-P 
vs Ctrl 
ADHD-P 
vs 
ADHD-R 
ADHD-R 
vs Ctrl 
 d p d p d p d p d p d p 
Perform
ance 
                 
Congrue
nt errors 
10.8
9 
(17.
26) 
4.00 
(3.8
5) 
4.14 
(8.3
1) 
<.0
1** 
.8
3 
<.0
1** 
.7
5 
<.0
1** 
.0
4 
.95 <.0
1** 
.5
5 
<.0
1** 
.6
0 
.01
** 
.0
9 
.89 
Incongru
ent 
errors 
57.8
7 
(20.
08) 
56.2
2 
(20.
75) 
48.8
7 
(18.
02) 
<.0
1** 
.5
3 
<.0
1** 
.0
6 
.86 .4
6 
.06
† 
<.0
1** 
.3
2 
.01
** 
.0
6 
.98 .3
7 
.11 
Congrue
nt MRT 
(ms) 
355.
82 
(60.
39) 
339.
58 
(38.
99) 
336.
25 
(33.
28) 
<.0
1** 
.4
1 
<.0
1** 
.2
8 
0.2
3 
.1
1 
0.6
3 
.28 - - - - - - 
Incongru
ent MRT 
(ms) 
449.
87 
(56.
16) 
441.
94 
(33.
44) 
431.
68 
(40.
75) 
<.0
1** 
.4
0 
<.0
1** 
.0
7 
.73 .3
5 
.07
† 
.44 - - - - - - 
Congrue
nt RTV 
(ms) 
114.
26 
(65.
70) 
83.1
9 
(28.
22) 
76.2
4 
(21.
67) 
<.0
1** 
1.
0
0 
<.0
1** 
.6
1 
<.0
1** 
.3
5 
.11 <.0
1** 
.6
0 
<.0
1** 
.4
2 
.04
* 
.1
4 
.25 
Incongru
ent RTV 
(ms) 
119.
31 
(80.
64) 
88.1
8 
(32.
91) 
76.1
2 
(22.
84) 
<.0
1** 
.9
7 
<.0
1** 
.4
7 
.04 .5
0 
.02
* 
<.0
1** 
.5
5 
<.0
1** 
.2
4 
.18 .3
0 
.08
† 
ERPs                  
N2 at Fz - - - .02 .3 .03 .0 .91 .2 .19 0.0 .2 .02 .0 .88 .2 .20 
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Abbreviations: ADHD-P = ADHD persisters, ADHD-R = ADHD remitters, Ctrl = Control group, SD = 
standard deviation, p = regression model significant testing, d = Cohen’s d effect size (0.20 small, 
0.50 medium and 0.80 large), Congruent = congruent condition, Incongruent = incongruent 
condition, MRT = reaction time of correct response to targets, RTV = reaction time variability to 
targets (i.e. SD of reaction time). 
Notes: Data on performance measures were available for the full sample (87 ADHD-P, 23 ADHD-R 
and 169 controls); data on the N2 were available for 84 ADHD-P, 23 ADHD-R and 169 controls; data 
on the PNe, ERN and Pe were available for 74 ADHD-P, 20 ADHD-R and 146 controls. 
Overall effects of group, condition (on cognitive-performance measures) and site (on the N2) and 
interaction effects were tested with mixed models and reported in Supplement 1, Table S2. Only 
group effects were tested on the ERN and Pe, thus regression models (rather than mixed models) 
were used. Age was also included as a covariate in all analyses and its effects not presented here for 
simplicity, but available upon requests.  
**p≤.01; *p≤.05; †p≤.09. 
(µV) 7.23 
(3.6
9) 
6.91 
(3.6
1) 
6.57 
(3.2
7) 
0 * 2 
 
9 3 5 1 6 
N2 at 
FCz (µV) 
-5.8  
(3.7
4) 
-
6.26 
(3.5
7) 
-
6.92 
(3.8
1) 
.07 .2
6 
.08
† 
.1
8 
.53 .0
8 
.82 0.1
1 
- - - - - - 
ERN at 
FCz (µV) 
7.78 
(3.3
7) 
9.64 
(4.1
1) 
10.0
8 
(4.5
1) 
<.0
1** 
.5
5 
<.0
1** 
.5
2 
.05 .0
6 
.86 <.0
1** 
.3
7 
<.0
1** 
.3
9 
.09
† 
.0
1 
.98 
Pe at CPz 
(µV) 
9.36  
(4.2
3) 
10.9
6 
(4.0
6) 
11.3
1 
(4.2
7) 
<.0
1** 
.4
4 
<.0
1** 
.4
4 
.05 .0
2 
.88 .03 .3
2 
.03 .3
6 
.06
† 
.0
6 
.79 
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Table 3. Pearson correlations (two-tailed) of cognitive performance and ERP measures with 
interview-based DIVA ADHD symptoms and clinical impairment within the ADHD group only 
(n=110), controlling for age and gender (left hand side), and controlling for IQ, age and gender 
(right hand side) 
Abbreviations: Congruent = congruent condition, Incongruent = incongruent condition, MRT = 
reaction time of correct response to targets, RTV = reaction time variability to targets (i.e. SD of 
reaction time). 
*p≤.05; †p≤.09.  
  
 ADHD symptoms Impairment ADHD symptoms 
(covarying IQ) 
Impairment 
(covarying IQ) 
Congruent errors 0.15 0.21* 0.10 0.17† 
Incongruent errors 0.07 0.03 0.05 <0.01 
Congruent MRT (ms) -0.11 0.001 0.07 -0.09 
Incongruent MRT (ms) 0.05 -0.07 -0.01 0.14 
Congruent RTV (ms) 0.21* 0.13 0.15 0.12 
Incongruent RTV (ms) 0.21* 0.18† 0.14 0.10 
N2 at Fz (µV) 0.04 0.18† 0.04 0.18† 
N2 at FCz (µV) 0.07 0.12 0.10 0.15 
ERN at FCz (µV) -0.01 -0.15 0.03 -0.11 
Pe at CPz (µV) -0.20* -0.20* -0.20* -0.20* 
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